HALEOS LABS
Back to Cashflow Statement
|
HALEOS LABS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-19 Cr | ₹-6.56 Cr | ₹17 Cr | ₹11 Cr | ₹-2.55 Cr |
What is the latest Cash Flow from Financing Activities ratio of HALEOS LABS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-19 Cr |
| Mar2024 | ₹-6.56 Cr |
| Mar2023 | ₹17 Cr |
| Mar2022 | ₹11 Cr |
| Mar2021 | ₹-2.55 Cr |
How is Cash Flow from Financing Activities of HALEOS LABS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-19 Cr | Negative | |
| Mar2024 | ₹-6.56 Cr | Negative | |
| Mar2023 | ₹17 Cr | 55.88 | |
| Mar2022 | ₹11 Cr | Positive | |
| Mar2021 | ₹-2.55 Cr | - | |
Compare Cash Flow from Financing Activities of peers of HALEOS LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HALEOS LABS | ₹480.0 Cr | 1.5% | 15.5% | 22.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹466,179.0 Cr | -0.4% | 4.3% | 13.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹196,095.0 Cr | 0.9% | 8.9% | 8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,530.0 Cr | 0.7% | 13% | 46.5% | Stock Analytics | |
| CIPLA | ₹114,318.0 Cr | -1% | -0% | -3.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,742.1 Cr | -3.3% | -8.4% | -4.3% | Stock Analytics | |
HALEOS LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HALEOS LABS | 1.5% |
15.5% |
22.9% |
| SENSEX | -0.6% |
-0.1% |
-6.7% |
You may also like the below Video Courses